Looking forward: pharma channels for 2021
We all know how much the pandemic has impacted the industry’s ability to engage with healthcare professionals (HPCs) and the extent to which companies have switched to digital to maintain HCP relationships. What interesting, however, is where those investments were being directed – and how that might change in the future.
Best practices in pharma remote HCP engagement
Remote detailing, and generally any kind of remote engagement, has been increasing steadily over the last decade. It was clear that it would have a big part to play in pharma sales and marketing in the future. Last year turbocharged that. Now it’s an essential channel – and is growing exponentially.
How modular content makes you more innovative
You’ve likely heard a lot about modular content over the last few years. It’s often described as being the future of content in pharma. But why? What exactly does it give you that traditional content doesn’t?
